Mikhail Blagosklonny teaches oncology at the Rowell Park Cancer Institute. A scientist by profession, he is well known for his extensive study on the subjects of cancer and Aging. His prowess in science is courtesy of his MD in internal medicine, earned from the first Pavlov State Medical University of St. Petersburg. He prides himself on having received a Ph.D. in Experimental Medicine and Cardiology from the same institution.In 2002, Mikhail became the associate medicine professor at the new york medical college in Valhalla, new york. Later on, he served as a senior scientist at the Ordway Research Institute. He then joined the Rosewell Park Institute in 2009, where he is the current professor of Oncology. His extensive experience made him a force to reckon with in the field of oncology. He mainly focuses his research on Biogerontology (the mechanisms of aging) cancer, anti-aging drugs, and targeted cancer therapies that guard the normal cell against damage.Mikhail Blagosklonny is the current editor in chief of the Oncotarget and Cell Cycle. On top of all the achievements mentioned above, he is also the associate editor of cancer therapy and biology.
He is a prominent member of the Cell Death and Differentiation editorial board. Indeed, his scientific knowledge in oncology is unrivaled by many, and this has seen him serve many organizations dedicated to curing cancer and finding a cure for aging.Mikhail’s contribution to the subject of aging is significant. He drafted a hypothesis that aimed at describing the potential role of TOR Signaling in cancer and aging. His theory is based on Rapamycin. Essentially, Rapamycin is a drug that has been popularly used to treat cancer. In his hypothesis, he suggests that Rapamycin and a few other clinical drugs can be used effectively to treat cancer and slow down the aging process in the human body. Although his hypothesis is still subject to review and further research, Mikhail has set the tone for scientific research on the topics of cancer treatment and combating aging. He strongly advocates for the use of Rapamycin to ensure that people live the longest life possible.
Although many people may primarily know Mikhail for his hypothesis, his research is quite diverse. His research subjects range from clinical investigations to cellular and molecular biology. Mikhail’s research mainly entails ontogenesis, signal transduction, tumor suppressors, apoptosis, drug resistance for normal cells selective protection, cell cycle mitosis, and anticancer therapy.In addition to his scientific research on traditional subjects such as aging and cancer, Mikhail has written critical articles on relevant topics such as chemotherapeutic engineering and cell cyclotherapy. He is also the author of the hyper function theory.Throughout his career, Mikhail has written over 300 research articles, reviews, and book chapters. His hard work and dedication are responsible for his prominence in oncology research today. He attributes his commitment to his work to his undying love for humanity and a vision for a disease free world.
Eric Lefkofsky is the co founder of and chief executive officer of a company known as Tempus. His company is one that has built an operating system that helps fight cancer. Along with Tempus, Eric is also the co founder and Managing Director of Ligthbank, which is a venture fund that invests in disruptive technologies. As well as being involved in the technology industry, Eric is also the co founder and chairman of Groupon which specializes in offering discounts on various forms of merchandise on the internet. He also leads another company called Uptake Technologies which is a leading predictive analytics company. With all of these companies, Eric has proven to be a very versatile businessperson.
Lefkofsky has also founded some more companies such as Mediaocean which is a company that specializes in media procurement technology. He has also founded Echo Global Logistics and InnerWorkings. These companies specialize in technology transportation and logistics outsourcing and managed print and promotional solutions respectively. All of these companies have allowed Eric to establish himself as a top entrepreneur in the United States.
One of the companies that Eric is in charge of is Tempus. This is a technology company that uses the advantage of technology to help fight cancer. The company allows physicians to deliver personalized cancer care with the use of an interactive analytical and machine learning platform. It also provides physicians with genomic sequencing services along with analysis of molecular and therapeutic data to make it easier for physicians to make data driven decisions at real time. The goal of Tempus is to provide benefits to each patient with treatment from physicians using the most updated data and technology.
While Eric Lefkofsky established himself as a successful entrepreneur, he has also been involved in a number of philanthropic activities. He established the Lefkofsky Family Foundation in 2006. This is a private chartable foundation that has helped advance initiatives to enhance the livelihood of people in the community. Eric is also the Trustee of Lurie Children’s Hospital of Chicago, The Art Institute of Chicago and also the Museum of Science and Industry and World Business Chicago to learn more: http://chicagoinno.streetwise.co/2016/07/22/eric-lefkofskys-next-move-curing-cancer-at-tempus/ click here.
When looking to follow and contact Eric Lefkofsky, you can go on Facebook, Twitter and LinkedIn. All of these sites provide information about Eric and his companies. He reveals the latest news about his companies as well as topics pertaining to them. With this social media presence, people interested in learning more about Eric Lefkofsky and his companies will have a very reliable source to go to. These sites will also make it easier for prospective customers to find out more about the services that Eric’s companies provide.
Lefkofsky is quite educated with a very impressive background in which he graduated from one of the most prestigious universities in the nation. He graduated from the University of Michigan with a bachelor’s degree along with earning his Juris Doctor from the University of Michigan Law School. As a graduate of Michigan, Eric was able to attain a high quality educational foundation that has allowed him to pursue his goals. After finishing college and law school, Eric had a combination of general education as well as legal education to help him start a lucrative career. He would eventually become an entrepreneur. Over the years, he would experience a considerable amount of success as he founded numerous companies.